Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole
Timothy Peters-Strickland,1 Linda Pestreich,1 Ainslie Hatch,2 Shashank Rohatagi,1 Ross A Baker,1 John P Docherty,2 Lada Markovtsova,1 Praveen Raja,3 Peter J Weiden,4 David P Walling5 1Otsuka Pharmaceutical Development & Commercialization, Inc., 2ODH, Inc., Princeton, NJ, 3Proteus Digita...
Saved in:
Main Authors: | Peters-Strickland T, Pestreich L, Hatch A, Rohatagi S, Baker RA, Docherty JP, Markovtsova L, Raja P, Weiden PJ, Walling DP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-10-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/usability-of-a-novel-digital-medicine-system-in-adults-with-schizophre-peer-reviewed-fulltext-article-NDT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamics of mental state and prolactin levels in patients with chronic schizophrenia during aripiprazole therapy
by: L. N. Gorobets, et al.
Published: (2023-10-01) -
Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study
by: Yi-Ting Yeh, et al.
Published: (2025-07-01) -
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
by: Kishi T, et al.
Published: (2016-11-01) -
Methods of correction of hyperprolactinemia induced by antipsychotics: current state of the problem and development prospects
by: G. E. Mazo, et al.
Published: (2024-06-01) -
Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review
by: Alessandro Pascucci, et al.
Published: (2025-07-01)